NCT06075199Recruiting
Intestinal Metaplasia Cohort for Gastric Cancer Prediction
A Prospective Cohort Study for Gastric Cancer Prediction in Patients With Intestinal Metaplasia
Source: ClinicalTrials.gov · Last updated 29 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In this study, we aim to establish a prospective cohort of patients with endoscopically and histologically confirmed intestinal metaplasia, collect gastric mucosal tissue samples from this cohort, and follow the development of gastric cancer over time.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 3 Oct 2023
- Start date
- 13 Sept 2023
- Primary completion date
- 30 Jun 2033
- Lead sponsor
- Seoul National University Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06075199
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 13 Sept 2023 to the primary completion date, 30 Jun 2033
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have been previously diagnosed with gastric cancer or adenoma
- Patients who have previously received gastrectomy
Who the study is looking for
- Patients who visit Seoul National University Hospital
- Patients who have been visually diagnosed with intestinal metaplasia at a prior exam
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul National University Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.